Literature DB >> 11518822

Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients.

P De Lonlay1, C Benelli, F Fouque, A Ganguly, B Aral, C Dionisi-Vici, G Touati, C Heinrichs, D Rabier, P Kamoun, J J Robert, C Stanley, J M Saudubray.   

Abstract

Hyperinsulinism and hyperammonemia syndrome has been reported as a cause of moderately severe hyperinsulinism with diffuse involvement of the pancreas. The disorder is caused by gain of function mutations in the GLUD1 gene, resulting in a decreased inhibitory effect of guanosine triphosphate on the glutamate dehydrogenase (GDH) enzyme. Twelve unrelated patients (six males, six females) with hyperinsulinism and hyperammonemia syndrome have been investigated. The phenotypes were clinically heterogeneous, with neonatal and infancy-onset hypoglycemia and variable responsiveness to medical (diazoxide) and dietary (leucine-restricted diet) treatment. Hyperammonemia (90-200 micromol/L, normal <50 micromol/L) was constant and not influenced by oral protein, by protein- and leucine-restricted diet, or by sodium benzoate or N-carbamylglutamate administration. The patients had mean basal GDH activity (18.3 +/- 0.9 nmol/min/mg protein) not different from controls (17.9 +/- 1.8 nmol/min/mg protein) in cultured lymphoblasts. The sensitivity of GDH activity to inhibition by guanosine triphosphate was reduced in all patient lymphoblast cultures (IC(50), or concentrations required for 50% inhibition of GDH activity, ranging from 140 to 580 nM, compared with control IC(50) value of 83 +/- 1.0 nmol/L). The allosteric effect of ADP was within the normal range. The activating effect of leucine on GDH activity varied among the patients, with a significant decrease of sensitivity that was correlated with the negative clinical response to a leucine-restricted diet in plasma glucose levels in four patients. Molecular studies were performed in 11 patients. Heterozygous mutations were localized in the antenna region (four patients in exon 11, two patients in exon 12) as well as in the guanosine triphosphate binding site (two patients in exon 6, two patients in exon 7) of the GLUD1 gene. No mutation has been found in one patient after sequencing the exons 5-13 of the gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518822     DOI: 10.1203/00006450-200109000-00010

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  20 in total

1.  A case of hyperinsulinism/hyperammonaemia syndrome with reduced carbamoyl-phosphate synthetase-1 activity in liver: a pitfall in enzymatic diagnosis for hyperammonaemia.

Authors:  K Ihara; K Miyako; M Ishimura; R Kuromaru; H-Y Wang; K Yasuda; T Hara
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Congenital hyperinsulinism with hyperammonaemia.

Authors:  Alex Pschibul; Jörg Müller; Hubert Fahnenstich
Journal:  BMJ Case Rep       Date:  2010-02-08

3.  Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.

Authors:  Dashuang Shi; Gengxiang Zhao; Nicholas Ah Mew; Mendel Tuchman
Journal:  Mol Genet Metab       Date:  2016-12-08       Impact factor: 4.797

Review 4.  Intertissue differences for the role of glutamate dehydrogenase in metabolism.

Authors:  Jason R Treberg; Sheena Banh; Umesh Pandey; Dirk Weihrauch
Journal:  Neurochem Res       Date:  2013-02-15       Impact factor: 3.996

Review 5.  Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties.

Authors:  Arianna Maiorana; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2017-06-27       Impact factor: 4.982

Review 6.  The hyperinsulinism/hyperammonemia syndrome.

Authors:  Andrew A Palladino; Charles A Stanley
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

Review 7.  N-acetylglutamate synthase: structure, function and defects.

Authors:  Ljubica Caldovic; Nicholas Ah Mew; Dashuang Shi; Hiroki Morizono; Marc Yudkoff; Mendel Tuchman
Journal:  Mol Genet Metab       Date:  2010-02-26       Impact factor: 4.797

8.  The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.

Authors:  Maria-João Ribeiro; Nathalie Boddaert; Christine Bellanné-Chantelot; Sandrine Bourgeois; Vassili Valayannopoulos; Thierry Delzescaux; Francis Jaubert; Claire Nihoul-Fékété; Francis Brunelle; Pascale De Lonlay
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-28       Impact factor: 9.236

9.  A severe case of hyperinsulinism due to hemizygous activating mutation of glutamate dehydrogenase.

Authors:  Mary Barrosse-Antle; Chang Su; Pan Chen; Kara E Boodhansingh; Thomas J Smith; Charles A Stanley; Diva D De León; Changhong Li
Journal:  Pediatr Diabetes       Date:  2017-02-06       Impact factor: 4.866

10.  Structure-based predictive models for allosteric hot spots.

Authors:  Omar N A Demerdash; Michael D Daily; Julie C Mitchell
Journal:  PLoS Comput Biol       Date:  2009-10-09       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.